EstechPharma Co. Ltd Asset Resilience Ratio
EstechPharma Co. Ltd asset resilience ratio. EstechPharma Co. Ltd (041910) has an Asset Resilience Ratio of 8.74% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EstechPharma Co. Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of EstechPharma Co. Ltd (2013–2025)
Asset resilience ratio of EstechPharma Co. Ltd from 2013 to 2025. This chart shows how EstechPharma Co. Ltd's Asset Resilience Ratio has changed over time. Read EstechPharma Co. Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down EstechPharma Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 041910 total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩17.12 Billion | 8.74% |
| Total Liquid Assets | ₩17.12 Billion | 8.74% |
Asset Resilience Insights
- Limited Liquidity: EstechPharma Co. Ltd maintains only 8.74% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
EstechPharma Co. Ltd Industry Peers by Asset Resilience Ratio
Compare EstechPharma Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
GeneBioTech Co. Ltd
KQ:086060 |
Pharmaceuticals | 22.68% |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 6.87% |
|
ST Pharm Co.Ltd
KQ:237690 |
Pharmaceuticals | 7.72% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 66.73% |
|
Komipharm International Co. Ltd
KQ:041960 |
Pharmaceuticals | 0.00% |
|
Mezzion Pharma Co.Ltd
KQ:140410 |
Pharmaceuticals | 0.00% |
|
Aprogen Healthcare & Games Inc
KQ:109960 |
Pharmaceuticals | 6.55% |
EstechPharma Co. Ltd Asset Resilience Ratio by Year (2013–2025)
EstechPharma Co. Ltd asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for EstechPharma Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 8.74% | ₩17.12 Billion ≈ $11.60 Million |
₩195.93 Billion ≈ $132.78 Million |
-25.99pp |
| 2024-12-31 | 34.72% | ₩46.68 Billion ≈ $31.64 Million |
₩134.45 Billion ≈ $91.12 Million |
+12.21pp |
| 2023-12-31 | 22.51% | ₩27.44 Billion ≈ $18.60 Million |
₩121.90 Billion ≈ $82.61 Million |
-2.09pp |
| 2022-12-31 | 24.60% | ₩30.58 Billion ≈ $20.72 Million |
₩124.32 Billion ≈ $84.25 Million |
-13.35pp |
| 2021-12-31 | 37.95% | ₩50.98 Billion ≈ $34.55 Million |
₩134.36 Billion ≈ $91.05 Million |
-3.60pp |
| 2020-12-31 | 41.54% | ₩51.16 Billion ≈ $34.67 Million |
₩123.15 Billion ≈ $83.46 Million |
+7.35pp |
| 2019-12-31 | 34.19% | ₩39.81 Billion ≈ $26.98 Million |
₩116.43 Billion ≈ $78.90 Million |
+10.08pp |
| 2018-12-31 | 24.12% | ₩23.72 Billion ≈ $16.07 Million |
₩98.34 Billion ≈ $66.65 Million |
+1.52pp |
| 2017-12-31 | 22.60% | ₩21.46 Billion ≈ $14.54 Million |
₩94.95 Billion ≈ $64.35 Million |
+2.16pp |
| 2016-12-31 | 20.43% | ₩19.92 Billion ≈ $13.50 Million |
₩97.47 Billion ≈ $66.06 Million |
+19.89pp |
| 2015-12-31 | 0.55% | ₩500.00 Million ≈ $338.84K |
₩91.36 Billion ≈ $61.92 Million |
-15.47pp |
| 2014-12-31 | 16.02% | ₩18.35 Billion ≈ $12.43 Million |
₩114.56 Billion ≈ $77.63 Million |
+16.00pp |
| 2013-12-31 | 0.02% | ₩20.00 Million ≈ $13.55K |
₩104.37 Billion ≈ $70.73 Million |
-- |
About EstechPharma Co. Ltd
EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.